Lilly To Continue Development Of Enzastaurin Despite Termination Of Glioblastoma Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Company remains optimistic and will pursue other indications, Lilly told “The Pink Sheet” DAILY.